| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |